Given that autoantibodies in PCa patients may be sensors or sentinels of events associated with prostate tumorigenesis [43], it would be tempting to speculate that the rise in cyclin B1 autoantibodies may reflect changes in the expression or activity of this protein in the patients. The gene discussed is CCNB1; the disease is posterior cortical atrophy.